NCT07311668

Brief Summary

The trial aimed to evaluate the accuracy of an artificial intelligence-based system for diagnosing depressive disorders. Specifically, it sought to determine whether the system's assessment validity is non-inferior to that of psychiatric specialists.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Feb 2026

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 17, 2025

Completed
1 month until next milestone

First Posted

Study publicly available on registry

December 31, 2025

Completed
1 month until next milestone

Study Start

First participant enrolled

February 1, 2026

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 15, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 15, 2026

Completed
Last Updated

December 31, 2025

Status Verified

August 1, 2025

Enrollment Period

1 month

First QC Date

November 17, 2025

Last Update Submit

December 29, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Diagnostic Accuracy (Sensitivity, Specificity, and Area Under the Curve) of the AI-Based Screening System for Depressive Disorders

    In this study, the evaluation results of the subjects were taken as the gold standard based on the diagnostic conclusions of psychiatrists. The screening results of the aided-diagnostic system were compared with the diagnostic conclusions of the psychiatrists to verify the screening effectiveness of this system. Sensitivity : Calculated as \[True Positives / (True Positives + False Negatives)\], evaluating the AI system's ability to correctly identify patients with depression. Specificity : Calculated as \[True Negatives / (True Negatives + False Positives)\], evaluating the AI system's ability to correctly exclude non-depressed individuals.Area Under the Receiver Operating Characteristic Curve (AUC), which comprehensively evaluates the diagnostic discriminative power of the system by plotting sensitivity versus 1-specificity across different decision thresholds and calculating the AUC value .

    through study completion, an average of 1 week

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

The study includes the subjects with depressive disorders and healthy control into the experiment. Depressive individuals for the study will be recruited from actual outpatient patients at the Shanghai Mental Health Center. The healthy control will be recruited through public advertisements, both online and offline. Psychiatrists will be recruited through public advertisements by the Shanghai Mental Health Center.

You may qualify if:

  • In accordance with ICD-11 for Depressive Disorders;
  • Between the ages of 18-60;
  • Ability to use computers or smartphone;
  • Native Chinese speaker;

You may not qualify if:

  • With severe psychiatric symptoms requiring hospitalization, or unable to complete the required assessment and treatment;
  • With a high risk of suicide or self-injury;
  • With severe physical diseases, central nervous system diseases, or substance abuse;
  • With intellectual, visual, or auditory impairments that affect their ability to interact with aided-diagnostic systems.
  • Not meet ICD-11 criteria for Mental Disorders;
  • Between the ages of 18-60;
  • Ability to use computers or smartphone;
  • Native Chinese speaker;
  • With mental illness, or unable to complete the required assessment and treatment;
  • With severe physical diseases, central nervous system diseases, or substance abuse;
  • With intellectual, visual, or auditory impairments that affect their ability to interact with aided-diagnostic systems.
  • Over 18 years old;
  • A minimum of three years' experience in anxiety and other mental health fields;
  • Intermediate or higher professional title;
  • Currently employed in the selected test region;
  • +1 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Shanghai Mental Health Center

Shanghai, Shanghai Municipality, 200030, China

Location

MeSH Terms

Conditions

Depressive Disorder

Condition Hierarchy (Ancestors)

Mood DisordersMental Disorders

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 17, 2025

First Posted

December 31, 2025

Study Start

February 1, 2026

Primary Completion

March 15, 2026

Study Completion

March 15, 2026

Last Updated

December 31, 2025

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will not share

Locations